• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR; INTESTINAL STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROMODULATION NEU_INS_STIMULATOR; INTESTINAL STIMULATOR Back to Search Results
Model Number NEU_INS_STIMULATOR
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Pain (1994)
Event Type  Injury  
Manufacturer Narrative
Continuation of medical devices: product id neu_ens_stimulator, product type external neurostimulator.Information references the main component of the system.Other relevant device(s) are: product id: neu_ens_stimulator.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Kirss, j., jr., pinta, t., varpe, p., rautio, t., kairaluoma, m., hyöty, m., hurme, s., böckelman, c., kairaluoma, v., salmenkylä, s., victorzon, m.Outcomes of treatment of faecal incontinence with sacral nerve stimulation - a finnish multicentre study.Colorectal dis.2018.Doi: 10.1111/codi.14406 summary: the aim of this multicentre study is to report the results of sacral nerve stimulation (sns) treatment for faecal incontinence (fi) in (b)(6) and determine factors that could influence sns treatment outcomes.Method this is a national multicentre study, involving all patients tested for sns implantation in (b)(6) from 1999-2017.Data were collected retrospectively from electronic patient archives and analysed for possible effects on treatment outcome.Of the 432 patients tested for fi with sns, 365 were female.313 (72.5%) of the tested patients advanced to permanent stimulator implantation.A successful final treatment outcome, with subjective alleviation of fi, was reported by 59.3% of the patients at the end of follow-up (mean 2.4 years, range: 8 days- 13.3 years).Patients with obstetric sphincter injury and idiopathic fi had more permanent stimulator implantations compared with patients with iatrogenic injury (p=0.012).Male patients had significantly worse test phase outcomes compared with female patients (p <(><<)>0.001).Age did not influence treatment outcome (p=0.446).Subjective final success of sns treatment for fi was achieved in 59.3% of patients at a mean of 2.4 years.Gender and aetiology of fi influenced the test phase and final treatment outcome of sns treatment.Reported events: there were 65 patients (15.0%) who experienced a complication during sns testing and 19 patients (4.4%) who experienced a complication after permanent stimulator placement.The most frequent complication that arose during the test phase was operation site infection (in 26 cases).Operation site pain was the most common complication after permanent stimulator implantation.These are presented in figure 1.Of the patients who experienced a complication during sns testing, 62.5% had a successful test phase, whereas 74.6% of the patients with no complications during testing had a successful test phase (p=0.046).A complication after permanent stimulator implantation had a significant negative effect on the final treatment outcome (p<(><<)>0.001) (table 1).Of the patients who experienced a complication during the test phase, 25 (40.3%) required the removal of the electrode and cessation of the test.In 2 cases (3.2%) the electrode was replaced and testing was see attached literature article.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEU_INS_STIMULATOR
Type of Device
INTESTINAL STIMULATOR
Manufacturer (Section D)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer (Section G)
MEDTRONIC NEUROMODULATION
800 53rd ave ne
minneapolis MN 55421 1200
Manufacturer Contact
lisa woodward clark
7000 central avenue ne rcw215
mansfield, MA 02048
7635263920
MDR Report Key8202346
MDR Text Key131589253
Report Number3007566237-2018-03724
Device Sequence Number1
Product Code LNQ
Combination Product (y/n)N
Reporter Country CodeFI
PMA/PMN Number
P080025
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 12/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEU_INS_STIMULATOR
Device Catalogue NumberNEU_INS_STIMULATOR
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received12/13/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-